Publications

You are currently filtering by: Rare Disease lung

2018 • Am J Respir Cell Mol Biol. 2018 Dec;59(6):723-732

Maisel K, Merrilees MJ, Atochina-Vasserman EN, Lian L, Obraztsova K, Rue R, Vasserman AN, Zuo N, Angel LF, Gow AJ, Kang I, Wight TN, Eruslanov E, Swartz MA, Krymskaya VP

Full Article
2018 • PLoS One. 2018 May 14;13(5):e0197105

Himes BE, Obraztsova K, Lian L, Shumyatcher M, Rue R, Atochina-Vasserman EN, Hur SK, Bartolomei MS, Evans JF, Krymskaya VP

Full Article
2017 • Molecular Cancer Research 15(10):1318-1330. PMID: 28710231.

Li C, Liu X, Liu Y, Zhang E, Medepalli K, Masuda K, Li N, Wikenheiser-Brokamp KA, Osterburg A, Borchers MT, Kopras EJ, Plas DR, Sun J, Franz DN, Capal JK, Mays M, Sun Y, Kwiatkowski DJ, Alayev A, Holz MK, Krueger DA, Siroky BJ, Yu JJ

Full Article
2017 • Modern Pathology 30(9):1223-1233. PMID: 28643793.

Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, Johnson SH, Serla V, Ryu JH, Yi ES, Kipp BR, Vasmatzis G, Carmona EM

Full Article
2017 • The Journal of Biological Chemistry 292(50):20528-20543. PMID: 28972182.

Stepanova V, Dergilev KV, Holman KR, Parfyonova YV, Tsokolaeva ZI, Teter M, Atochina-Vasserman EN, Volgina A, Zaitsev SV, Lewis SP, Zabozlaev FG, Obraztsova K, Krymskaya VP, Cines DB

Full Article
2017 • Oncotarget 8(22):36628-36638. PMID: 28410230.

Li X, Liu X, Zhang L, Li C, Zhang E, Ma W, Fan Q, Yu JJ

Full Article
2017 • The American Journal of Pathology 187(8):1750-1762. PMID: 28623674.

Dongre A, Clements D, Fisher AJ, Johnson SR

Full Article
Rare Disease • 2016 • Orphanet Journal of Rare Diseases 11(1): 67. PMID: 27194137.

Mori M, Dictor M, Brodszki N, López-Gutiérrez JC, Beato M, Erjefält JS, Eklund EA

Full Article
Rare Disease • 2014 • PLoS One 9(10): e104809. PMID: 25347447.

Li C, Zhang E, Sun Y, Lee PS, Zhan Y, Guo Y, Osorio JC, Rosas IO, Xu KF, Kwiatkowski DJ, Yu JJ

Full Article
Rare Disease • 2014 • American Journal of Respiratory Critical Care Medicine 189(2): 214-222. PMID: 24160862.

Blackwell TS, Tager AM, Borok Z, et al

Full Article
1 2

NDRI is a Not-For-Profit (501c3) Corporation.